Drug resistance in tuberculosis in India

Indian Journal of Medical Research

Volumn 120, Issue 4, 2004, Pages 377-386

  Paramasivan, C N ^a   Venkataraman, P ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

Author keywords

Current status; Drug resistance; India; Tuberculosis

Indexed keywords

AMINOSALICYLIC ACID; ETHAMBUTOL; ISONIAZID; RECOMBINANT INTERLEUKIN 2; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; THIOACETAZONE; TUBERCULOSTATIC AGENT;

BACTERIUM ISOLATE; CLINICAL TRIAL; DISEASE CONTROL; DISEASE TRANSMISSION; DRUG MONITORING; DRUG SENSITIVITY; DRUG SURVEILLANCE PROGRAM; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; HUMAN; INDIA; MYCOBACTERIUM TUBERCULOSIS; POPULATION DISTRIBUTION; POPULATION RESEARCH; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

DISEASE MANAGEMENT; DRUG RESISTANCE; HUMANS; INDIA; PREVALENCE; PUBLIC HEALTH PRACTICE; TUBERCULOSIS, MULTIDRUG-RESISTANT; WORLD HEALTH;

EID: 8644251324     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. World Health Organization. WHO report on the tuberculosis epidemic. WHO/TB/97.223. Geneva: WHO; 1997.
2. Joshi PL. HIV/AIDS in India. Ranbaxy Science Foundation Round Table Conference Series 2000; 6 : 27-32.
3. Mitchison, DA. Drug resistance in mycobacteria. Br Med Bull 1984; 40 : 84-90.
4. WHO/IUATLD. Global Project on Anti-tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world Report No.2. WHO/CDS/TB/2000.278.
5. Snider DE Jr, Kelley GD, Cauthen GM, Thompson NJ, Kilburn JO. Infection and disease among contacts of tuberculosis cases with drug resistant and drug susceptible bacilli. Am Rev Respir Dis 1985; 132 : 125-32.
6. Devaki V, Mohan K, Gangadharam PRJ. Direct sensitivity test for isoniazid. Indian J Med Res 1969; 57 : 1006-10.
7. Mathew S, Paramasivan CN, Rehman F, Bolambal R, Rajaram K, Prabhakar R. A direct rifampicin sensitivity test for tubercle bacilli. Indian J Med Res 1995; 102 : 99-103.
8. World Health Organization. WHO/IUATLD Global Working Group on Antituberculosis Drug Resistance Surveillance. Guidelines for surveillance of drug resistance in tuberculosis. Geneva. WHO/TB/96.216. 1997
9. World Health Organization. The WHO/IUATLD. Global Project on Antituberculosis Drug Resistance Surveillance: Antituberculosis drug resistance in the world. Report No.3. Geneva: Switzerland; 2004. WHO/CDS/TB/2004.
10. Paramasivan CN. An overview of drug resistant tuberculosis in India. Indian J Tuberc 1998; 45 : 73-81.
11. Paramasivan CN, Bhaskaran K, Venkataraman P, Chandrasekaran V, Narayanan PR. Surveillance of drug resistance in tuberculosis in the state of Tamil Nadu. Indian J Tuberc 2000; 47 : 27-33.
12. Paramasivan CN, Venkataraman P, Chandrasekaran V, Bhat S, Narayanan PR. Surveillance of drug resistance tuberculosis in two districts of south India. Int J Tuberc Lung Dis 2002; 6 : 479-84.
13. Indian Council of Medical Research. Prevalence of drug resistance in patients with pulmonary tuberculosis presenting for the first time with symptoms at chest clinics in India. I: Findings in urban clinics among patients giving no history of previous chemotherapy. Indian J Med Res 1968; 56 : 1617-30.
14. Indian Council of Medical Research. Prevalence of drug resistance in patients with pulmonary tuberculosis presenting for the first time with symptoms at chest clinics in India. II. Findings in urban clinics among all patients, with or without history of previous chemotherapy. Indian J Med Res 1969; 57 : 823-35.
15. Paramasivan CN, Chandrasekaran V, Santha T, Sudarsanam NM, Prabhakar R. Bacteriological investigations for short course chemotherapy under the tuberculosis programme in two districts of India. Tubercle Lung Dis 1993; 74 : 23-7.
16. Datta M, Radhamani MP, Selvaraj R, Paramasivan CN, Gopalan BN, Sudendra CR, et al. Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme. Tubercle Lung Dis 1993; 74 : 180-6.
17. Gopi PG, Vallishayee RS, Appegowda BN, Paramasivam CN, Ranganatha S, Venkataramu KV, et al. A tuberculosis prevalence survey based on symptoms questioning and sputum examination. Indian J Tuberc 1997; 44 : 171-80.
18. Chandrasekaran S, Chauhan MM, Rajalakshmi R, Chaudhuri K, Mahadev B. Initial drug resistance to anti-tuberculosis drugs in patients attending an urban district tuberculosis centre. Indian J Tuberc 1990; 37 : 215-6.
19. Chandrasekaran S, Jagota P, Chaudhuri K. Initial drug resistance to anti-tuberculosis drugs in urban and rural district tuberculosis programme. Indian J Tuberc 1992; 39 : 171-5.
20. Krishnaswamy KV, Rahim MA. Primary drug resistance in pulmonary tuberculosis. Indian J Chest Dis 1976; 28 : 233-7.
21. Narang P, Nayyar S, Mendiratta DK, Tyagi NK, Jajoo UN. Smear and culture positive cases of tuberculosis found among symptomatics surveyed in Wardha district. Indian J Tuberc 1992; 39 : 159-63.
22. Trivedi SS, Desai SC. Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat, India. Tubercle 1988; 69 : 37-42.
23. Gupta PR, Singhal B, Sharma TN, Gupta RB. Prevalence of initial drug resistance in tuberculosis patients attending a chest hospital. Indian J Med Res 1993; 97 : 102-3.
24. Kim SJ, Hong YP. Drug resistance of Mycobacterium tuberculosis in Korea. Tuberc Lung Dis 1992; 73 : 219-24.
25. Jain NK, Chopra KK, Prasad G. Initial and acquired isoniazid and rifampicin resistance to Mycobacterium tuberculosis and its implication for treatment. Indian J Tuberc 1992; 39 : 121-4.
26. Jena J, Panda BN, Nema SK, Ohri VC, Pahwa RS. Drug resistance pattern of Mycobacterium tuberculosis in a chest diseases hospital of armed forces. Lung India 1995; 13 : 56-9.
27. Vasanthakumari R, Jagannath K. Multidrug resistant tuberculosis - A Tamil Nadu study. Lung India 1997; 15 : 178-80.
28. Mitchison DA, Nunn AJ. Influence of initial drug resistance on the response to short course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis 1986; 133 : 423-30.
29. Mathew R, Santha T, Parthasarathy R, Rajaram K, Paramasivan CN, Janardhanam B, et al. Response of patients with initially drug-resistant organisms to treatment with short-course chemotherapy. Indian J Tuberc 1993; 40 : 119.
30. Jawahar MS. Multi-drug resistant tuberculosis. ICMR Bull 1999; 29 : 105-14.
31. Park SK, Kim CT, Song SD. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampicin. Int J Tuberc Lung Dis 1998; 2 : 877-84.
32. Iseman MD. Treatment of multidrug resistant tuberculosis in well-resourced countries. The 32nd IUATLD World Conference on Lung Health (Paris), 1-4 November 2001.
33. Iwanaga T, Yokota K, Kishikawa R, Ikeda T, Tsurutani H, Hirose T, et al. The combination of amoxicillin-clavulanic acid and ofloxacin in the treatment of multidrug-resistant Mycobacterium tuberculosis. Kekkaku 1997; 72 : 9-13.
34. Lee CN, Lin TP, Chang MF, Jimenez MV, Dolfi L, Olliaro P, et al. Rifabutin as salvage therapy for cases of chronic multi-drug resistant pulmonary tuberculosis in Taiwan. J Chemother 1996; 8 : 137-43.
35. Johnson BJ, Bekker LG, Rickman R, Brown S, Losser M, Ress S, et al. rhulL-2 adjunctive therapy in multidrug resistant tuberculosis: a comparison of two treatment regimens and placebo. Tuberc Lung Dis 1997; 78 : 195-203.